Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma
January 19, 2021CAMBRIDGE, England–(BUSINESS WIRE)–FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY
The Mundipharma network of independently associated companies today announced two new appointments to their Executive Committee – Julie Dehaene-Puype as Chief Commercial Officer, Europe and Erik Nordkamp as Chief Commercial Officer, LAM (Latin America, Asia Pacific, Middle East-Africa) – both reporting into Marc Princen, Chief Executive Officer.
Speaking of the appointments, Marc Princen commented, “I am delighted to welcome Julie and Erik as highly experienced pharmaceutical leaders to complete our global organisation. They join us during a pivotal year for some of our pipeline assets as we continue to increase access to healthcare for many of the world’s most challenging diseases.”
Julie Dehaene-Puype is joining Mundipharma with over 20 years’ industry experience from Takeda, Merck and Schering Plough, where she has held strategic and operational roles at country, regional and global level across the US, Europe and Canada. Julie joins Mundipharma from Takeda where she was recently General Manager of France. Her role at Mundipharma will see her cover the Europe region.
“I am thrilled to be joining the Mundipharma global organisation,” Julie commented. “I am looking forward to utilising my experience to build on the inclusive culture that enables our people to work together, think differently and to transform the lives of patients all around the world.”
Erik Nordkamp is a pharmaceutical professional with over 20 years’ experience in strategy, general management and marketing from Pfizer and Eli Lilly, with regional roles that have spanned Europe, Canada and Australia. Most recently Erik was Regional VP & Cluster Lead Europe/Australia/NZ Upjohn Division at Pfizer. His new role at Mundipharma will see him cover the LAM region, which encompasses Latin America, Asia Pacific, Middle East-Africa.
Commenting on his appointment, Erik said: “This is an exciting time for Mundipharma as we expand our global network and I feel proud to be taking responsibility for the key LAM region. Think global, act local is how I envision we can deliver lasting change for patients.”
-Ends-
Notes to editors:
About the Mundipharma network
Mundipharma is a global (ex-US) network of independent associated companies with a presence across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East.
As a dynamic, forward-looking organisation we are dedicated to bringing innovative treatments to patients in the areas of Pain & Supportive Care and Consumer Healthcare as well as other severe and debilitating disease areas.
Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do.
For more information visit www.mundipharma.com
Contacts
Helen Rae
[email protected]
T: +44 (0) 23 81 247 327
Rob Gallo
[email protected]
T: +44 (0) 7773 009578